quinidine has been researched along with ledipasvir in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agarwal, G; Banerjee, M; Bommakanti, A; Borhade, P; Das, AK; Dash, A; Dhayagude, U; Goswami, A; Gote, G; Gundu, J; Joshi, AA; Kamboj, RK; Kuldharan, S; Kumar, H; Loriya, R; Mallurwar, S; Mehta, M; Modi, D; Modi, F; Narasimham, L; Nigade, P; Palle, VP; Patil, V; Ramdas, V; Sharma, S; Singh, M; Sivaram, A; Srivastava, P; Talwar, R; Walke, DS | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
2 other study(ies) available for quinidine and ledipasvir
| Article | Year |
|---|---|
Discovery and Characterization of Potent Pan-Genotypic HCV NS5A Inhibitors Containing Novel Tricyclic Central Core Leading to Clinical Candidate.
Topics: Antiviral Agents; Genotype; Hepacivirus; Molecular Structure; Structure-Activity Relationship; Viral Nonstructural Proteins | 2019 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |